Clinical trial
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00319306 |
|---|---|
| Title | Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy |
| Official title | Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy |
| Acronym | RELEASE |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Device, Drug |
| Interventions | Budesonide/formoterol, Symbicort® Turbohaler® |
| Enrollment | 550 |
| Start date | Sep 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Mar 17, 2009 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: